 adopted by more than 40 other organizations,
incorporates an evaluation of the strength of the evidence
and the risks/benefits of implementing the recommendation. For the purposes of this review, we placed the highest
priorities on reducing overall stroke risk, periprocedural
stroke risk, and periprocedural mortality. Lesser importance was given to reducing nonfatal MI, cost, and the
ability to perform a percutaneous procedure. Recommendations are characterized as strong GRADE 